For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...

GlobalData’s Revati Tatake discussed key trends in biopharma which are set to have an impact in 2025 and beyond.

A new study suggests popular weight-loss drugs like Ozempic and Zepbound may be linked to rare eye conditions that could ...